Correlation Between Lifecore Biomedical and Allovir

Can any of the company-specific risk be diversified away by investing in both Lifecore Biomedical and Allovir at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lifecore Biomedical and Allovir into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lifecore Biomedical and Allovir, you can compare the effects of market volatilities on Lifecore Biomedical and Allovir and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lifecore Biomedical with a short position of Allovir. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lifecore Biomedical and Allovir.

Diversification Opportunities for Lifecore Biomedical and Allovir

-0.6

Correlation Coefficient

Lifecore Biomedical  Allovir

Excellent diversification

The 3 months correlation between Lifecore and Allovir is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Lifecore Biomedical and Allovir in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allovir and Lifecore Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lifecore Biomedical are associated (or correlated) with Allovir. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allovir has no effect on the direction of Lifecore Biomedical i.e., Lifecore Biomedical and Allovir go up and down completely randomly.

Pair Corralation between Lifecore Biomedical and Allovir

Given the investment horizon of 90 days Lifecore Biomedical is expected to generate 1.12 times more return on investment than Allovir. However, Lifecore Biomedical is 1.12 times more volatile than Allovir. It trades about 0.04 of its potential returns per unit of risk. Allovir is currently generating about -0.04 per unit of risk. If you would invest  699.00  in Lifecore Biomedical on October 9, 2024 and sell it today you would lose (12.00) from holding Lifecore Biomedical or give up 1.72% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Lifecore Biomedical  vs.  Allovir

Lifecore Biomedical

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Lifecore Biomedical are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting fundamental indicators, Lifecore Biomedical reported solid returns over the last few months and may actually be approaching a breakup point.

Allovir

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Allovir has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Lifecore Biomedical and Allovir

The main advantage of trading using opposite Lifecore Biomedical and Allovir positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lifecore Biomedical position performs unexpectedly, Allovir can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will offset losses from the drop in Allovir's long position.

The idea behind Lifecore Biomedical and Allovir pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.